Xi'an Tianlong Science and Technology
Xi'an Tianlong Science and Technology is a privately held Chinese molecular diagnostics manufacturer founded in 1997, producing PCR instruments, nucleic acid extractors, and over 600 reagent kits for clinical labs, public health agencies, blood banks, food safety, veterinary, and research customers in 100+ countries.
- Company typePrivate
- Founded1997
- HeadquartersXian Shi, China
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Xi'an Tianlong Science and Technology does
Xi'an Tianlong Science and Technology Co., Ltd. (天隆科技) is a privately held Chinese in vitro diagnostics manufacturer founded in 1997 and headquartered in the Economic & Technological Development Zone of Xi'an, Shaanxi Province. The company designs, develops, and manufactures molecular diagnostics instruments and reagents, with a portfolio spanning nucleic acid extractors (GeneRotex 96, Aurora PANA X6), real-time PCR systems (Gentier 96E, Gentier X3 Series, Gentier Mini+), all-in-one molecular diagnosis systems (Panall 8000), automated workstations (PANA 9600S, PANA S401, GeneMix Pro), portable point-of-care devices (iGenecase 1600, Biolum ATP Monitoring System Pro), and more than 600 compatible reagent kits covering respiratory infections, sexually transmitted infections, blood screening, viral hepatitis, oncology, maternal and child health, pharmacogenomics, tropical and zoonotic diseases, gastrointestinal infections, animal health, and food safety. The company also offers OEM/ODM services and integrated laboratory solutions such as the Tianlong Smart Lab Solution.
Tianlong sells to clinical diagnostic laboratories, public health and epidemic prevention agencies, blood banks, food safety testing facilities, veterinary laboratories, and scientific research institutions, distributing through direct enterprise sales, an international distributor network spanning more than 100 countries, and an online mall. The company holds more than 300 autonomous intellectual property rights, more than 90 China NMPA approvals, and more than 300 international certifications (including CE, MHRA, and AOAC), and has participated in formulating China's first Nucleic Acid Extraction Equipment Standard and first Fluorescence PCR Equipment Standard. R&D infrastructure includes a postdoctoral innovation center (established 2013) and an academician workstation (established 2017), and the company leads a National Key R&D Program under China's 14th Five-Year Plan.
The business model is primarily hardware sales of instruments paired with recurring revenue from proprietary reagent kits, supplemented by OEM/ODM licensing arrangements. Pricing is not publicly disclosed and is quote-based through direct inquiry. The company maintains strategic technology partnerships with Seegene (Korea), AIT Singapore, Pentabase (Denmark), and KHB (Shanghai Kehua Bio-Engineering), and has signaled adjacent expansion into chemiluminescence immunoassay through the Polaris V150 product announced for 2026 exhibition.
Xi'an Tianlong Science and Technology firmographics
Firmographics- Name
- Xi'an Tianlong Science and Technology
- Legal name
- Xi'an Tianlong Science and Technology Co., Ltd.
- Website
- https://medtl.net
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Xi'an Tianlong Science and Technology is a privately held Chinese molecular diagnostics manufacturer founded in 1997, producing PCR instruments, nucleic acid extractors, and over 600 reagent kits for clinical labs, public health agencies, blood banks, food safety, veterinary, and research customers in 100+ countries.
- Ownership category
- akta.pro rank
Xi'an Tianlong Science and Technology industry classification
Industry- Product category
- In Vitro Diagnostics (Molecular Diagnostics)
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
- akta.pro secondary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Xi'an Tianlong Science and Technology is headquartered
LocationHeadquarters
- HQ city
- Xian Shi
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Xi'an Tianlong Science and Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Nucleic Acid Testing Instruments and Systems: Sale of proprietary instruments including nucleic acid extractors, real-time PCR systems, automatic nucleic acid workstations, and all-in-one molecular diagnosis systems. The company designs and manufactures its own instrument portfolio targeting clinical, research, and industrial laboratories.
- Diagnostic Reagents and Testing Kits: Sale of over 600 compatible kits covering diverse applications including respiratory infections (SARS-CoV-2, influenza), sexually transmitted infections (HPV, HIV), blood screening, viral hepatitis, oncology diseases, maternal and child health, tropical infections, gastrointestinal infections, pharmacogenomics, animal health, and food safety testing.
- OEM/ODM Services: The company provides original equipment manufacturing and original design manufacturing services for molecular diagnostic products, allowing other companies to customize products under their brand.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Xi'an Tianlong Science and Technology product offering
Product offeringCore offering
Tianlong designs, manufactures, and sells molecular diagnostic instruments and reagent kits for nucleic acid testing. Its portfolio spans automated nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis workstations, portable point-of-care devices, and over 600 compatible reagent kits covering respiratory infections, blood screening, hepatitis, HPV, oncology, pharmacogenomics, animal health, and food safety applications. The company also provides integrated laboratory solutions and OEM/ODM services.
Product overview
Tianlong is an in vitro diagnostic device and PCR diagnostics company offering a broad portfolio of molecular diagnostics products and total solutions. The portfolio spans automated instruments (nucleic acid extractors, real-time PCR systems, automated workstations, all-in-one molecular diagnosis systems, and portable diagnostic devices) alongside over 600 compatible reagent kits covering respiratory infections, sexually transmitted infections, viral hepatitis, blood screening, oncology, maternal and child health, pharmacogenomics, tropical/zoonotic diseases, animal health, food safety, and gastrointestinal infections. Key instrument families include the Panall 8000 (all-in-one molecular diagnosis), Gentier series (real-time PCR), GeneRotex/GeneFlex/Libex (nucleic acid extraction), PANA series (lab automation), and Biolum (ATP hygiene monitoring). Tianlong provides OEM/ODM services and complete laboratory solutions, with products marketed in over 100 countries and regions.
Differentiator
Problem solved
Functional benefit
Brands
- Official Mall: The company's e-commerce platform for purchasing Tianlong diagnostic products.
Products and services
- Panall 8000 All-In-One Molecular Diagnosis System Fully automated molecular diagnosis system integrating sample tube decapping/capping, sample loading, nucleic acid extraction, PCR setup, PCR detection, and result analysis in a single walkaway workflow, designed for high-throughput clinical laboratories.
- Panall 8000 All-In-One Molecular Diagnosis System (Open System)
- Gentier 96E Real-Time PCR System
- Gentier X3 Series Real-Time PCR System Real-time PCR system with three independently controlled blocks, allowing users to save time and budget while processing multiple runs concurrently; features 2-second 32-well fluorescence scanning.
- Gentier Mini+ 4 Channels Portable Real-Time PCR System
- GeneRotex 96 Nucleic Acid Extractor
- Aurora PANA X6 Automated Nucleic Acid Extraction System
- Biolum Portable ATP Monitoring System Pro Portable ATP hygiene monitoring system providing rapid and accurate sanitation verification data in 10 seconds per test, with a web-based platform requiring no software downloads.
- iGenecase 1600 Diagnostics-in-a-Suitcase
- PANA 9600S Automatic Nucleic Acid Workstation
- PANA S401 Automated Liquid Handling System
- RBT320 Automatic Brucellosis Detection System
- Nucleic Acid Extraction Kit
- Respiratory Infections Kit
- Blood Screening Kit
- Human Papilloma Virus (HPV) PCR Detection Kit
- Viral Hepatitis Kit
- Sexually Transmitted Infections Kit
- Herpes Viruses Kit
- Monkeypox Virus Nucleic Acid Detection Kit
- Tropical Infections & Zoonoses Kit
- Animal Health Kit
- Pharmacogenomics Kit
- Oncology Diseases Kit
- Maternal and Child Health Kit
- Food Safety Monitoring Kit
- Gastrointestinal Infection Kit
- All-In-One Solution for Nucleic Acid Testing Laboratories
- Tianlong Smart Lab Solution
- Environmental Health Monitoring Solutions
- OEM/ODM Services
- Polaris V150 Chemiluminescence Immunoassay Analyzer Chemiluminescence immunoassay analyzer to be showcased at WHX Bangkok 2026 as part of Tianlong's molecular diagnostics portfolio expansion into immunoassay-based testing.
- Integrated Blood Screening Solution for Transfusion Safety Integrated blood screening solution with high automation, high throughput, and high-sensitivity NAT reagents for early detection of HIV, HBV, and HCV for blood banks and transfusion safety applications.
Quantifiable outcome
- Blood screening solutions with high automation, high throughput, and high-sensitivity NAT reagents for early detection of HIV, HBV, and HCV
Companies that use Xi'an Tianlong Science and Technology
Customer profileNamed customers3 records
Segments5 records
Ideal customer profiles6 records
Xi'an Tianlong Science and Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Feature9 records
Xi'an Tianlong Science and Technology partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered strategic and core.
- SeegenestrategicStrategic technology partnership for molecular diagnostics development. Seegene is a leading Korean molecular diagnostics company known for its syndromic testing solutions and multiplex PCR technologies.
- AIT SingaporecorePartnership with AIT Singapore for diagnostic technology exchange and collaboration. AIT (Agency for Science, Technology and Research) is Singapore's lead government agency for scientific research and development.
- KHB (Shanghai Kehua Bio-Engineering)coreComprehensive oncology detection solution partnership. Tianlong and KHB combined their respective strengths in molecular diagnostics and immunoassay to offer comprehensive cancer testing solutions to healthcare providers.
Scale indicators5 records
Recent moves5 records
Expansion highlights7 records
Xi'an Tianlong Science and Technology competitors and assessment
Company assessmentDirect peers
- BGI Genomics: Largest Chinese genomics and molecular diagnostics company offering PCR-based sequencing and IVD reagents for clinical, research, and public health applications across global markets — directly comparable in scale, geography, and product breadth to Tianlong.
- Sansure Biotech: Hunan-based Chinese IVD company specializing in molecular diagnostic kits (infectious diseases, reproductive health, oncology) and automated nucleic acid detection systems, with overlapping PCR instrument-plus-kit portfolio and similar tier-3 hospital go-to-market.
- DAAN Gene: Major Chinese molecular diagnostics firm with broad PCR-based infectious disease, genetic, and oncology reagent menu plus real-time PCR instruments — directly overlaps Tianlong's reagent catalog and clinical lab customer base in China and emerging markets.
- Cepheid (Danaher): Global leader in molecular PCR diagnostics via the GeneXpert system with deep US/EU installed base across clinical and reference laboratories; competes directly with Tianlong in real-time PCR and benchtop molecular systems for infectious disease testing.
- bioMérieux (BioFire): Global in vitro diagnostics leader whose BioFire FilmArray syndromic panels dominate multiplex molecular testing; competes with Tianlong's respiratory infection and zoonotic panels in hospital and reference lab markets worldwide.
- Qiagen: Global provider of sample-preparation technologies and PCR-based test kits for molecular diagnostics and research; directly overlaps Tianlong's nucleic acid extraction reagent and real-time PCR consumables businesses.
- Seegene: Korean molecular diagnostics company specializing in multiplex syndromic PCR technologies and a Tianlong technology partner/competitor; overlapping respiratory, STI, and gastroenteritis multiplex kit portfolios.
Broad incumbents
- Hologic: Diversified women's health and molecular diagnostics company operating the Panther/Panther Fusion automated molecular platform; competes in high-throughput nucleic acid testing markets where Tianlong sells Gentier and Panall 8000 systems.
- Roche Diagnostics: World's largest IVD provider operating cobas real-time PCR and cobas Liat systems across clinical labs; competes broadly with Tianlong's infectious-disease PCR franchise especially in European hospital and blood-bank segments.
- Autobio Diagnostics: Major Chinese clinical diagnostics and IVD manufacturer with broad immunoassay, clinical chemistry, and microbiology portfolio; competes with Tianlong in the Chinese hospital lab market with a larger overall scale and broader menu.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Xi'an Tianlong Science and Technology social profiles
Digital presenceXi'an Tianlong Science and Technology compliance and trust
Trust signalCompliance6 records
Xi'an Tianlong Science and Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Xi'an Tianlong Science and Technology leadership team
Management profileNumber of profiles
Xi'an Tianlong Science and Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Xi'an Tianlong Science and Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Xi'an Tianlong Science and Technology
What does Xi'an Tianlong Science and Technology do?
Tianlong designs, manufactures, and sells molecular diagnostic instruments and reagent kits for nucleic acid testing. Its portfolio spans automated nucleic acid extractors, real-time PCR systems, all-in-one molecular diagnosis workstations, portable point-of-care devices, and over 600 compatible reagent kits covering respiratory infections, blood screening, hepatitis, HPV, oncology, pharmacogenomics, animal health, and food safety applications. The company also provides integrated laboratory solutions and OEM/ODM services.
Is Xi'an Tianlong Science and Technology a public or private company?
Xi'an Tianlong Science and Technology is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Xi'an Tianlong Science and Technology founded?
Xi'an Tianlong Science and Technology was founded in 1997. It employs 51 to 100 people.
Where is Xi'an Tianlong Science and Technology based?
Xi'an Tianlong Science and Technology is headquartered in Xian Shi, China, in the Asia region.
How does Xi'an Tianlong Science and Technology make money?
Three revenue lines are on record. Nucleic Acid Testing Instruments and Systems are the primary driver. The others are diagnostic Reagents and Testing Kits and OEM/ODM Services.
Who are Xi'an Tianlong Science and Technology's main competitors?
Direct peers on record are BGI Genomics, Sansure Biotech, DAAN Gene, Cepheid (Danaher), bioMérieux (BioFire), Qiagen and Seegene. Broad incumbents are Hologic, Roche Diagnostics and Autobio Diagnostics.
Does Xi'an Tianlong Science and Technology have an API?
No public API is recorded for Xi'an Tianlong Science and Technology.
What industry is Xi'an Tianlong Science and Technology in?
Xi'an Tianlong Science and Technology's product category is In Vitro Diagnostics (Molecular Diagnostics). Its primary akta.pro industry code is HLAHAAAD, Molecular Diagnostics (PCR/NAAT/NGS-based IVD), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.